| Current Price | $131.18 | Mkt Cap | $6.7B |
|---|---|---|---|
| Open | $124.00 | P/E Ratio | 0.00 |
| Prev. Close | $131.18 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $121.74 - $136.34 | Volume | 647 |
| 52-Wk Range | $6.26 - $189.40 | Avg. Daily Vol. | 4,202,585 |
A biopharmaceutical company focused on creating differentiated, value-added vaccines that improve upon current preventive options for a range of infectious diseases.
| Current Price | $131.18 | Mkt Cap | $6.7B |
|---|---|---|---|
| Open | $124.00 | P/E Ratio | 0.00 |
| Prev. Close | $131.18 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $121.74 - $136.34 | Volume | 647 |
| 52-Wk Range | $6.26 - $189.40 | Avg. Daily Vol. | 4,202,585 |
The best Bull and Bear pitches based on recency and number of recommendations.
The company has two billion-dollar drugs in the pipeline.The first is a vaccine to combat RSV, the most common cause of bronchitis and pneumonia in babies. This is a multi-billion dollar drug. We are all waiting on phase 3 results.What made it a… More
This company was opportunistic in getting orders and cash from Operation Warp Speed. Management is clearly prepping for growth but I will need to see syringes of vaccine with their name on it before I believe they can bring a drug to market.
Read the most recent pitches from players about NVAX.
Recs
elevate88
(< 20)
Submitted: 1/25/2021 5:01:00 AM :
Start Price:
$123.15
NASDAQ:NVAX Score:
+8.93
Covid-19 vaccine
Recs
tomfoolme
(77.84)
Submitted: 1/15/2021 4:02:45 PM :
Start Price:
$128.89
NASDAQ:NVAX Score:
+2.82
biopharmaceutical company focused on creating differentiated, value-added vaccines that improve upon current preventive options for a range of infectious 6.6B pe- div-.
Recs
Luvy0712
(46.56)
Submitted: 1/5/2021 10:38:25 PM :
Start Price:
$112.01
NASDAQ:NVAX Score:
+15.84
Phase 3 trial for Covid Vaccine.
Find the members with the highest scoring picks in NVAX.
stockcaps360 (< 20) Score: +12,224.17
The Score Leader is the player with the highest score across all their picks in NVAX.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| qqqaaazzz | < 20 | 8/1/2017 |
|
5Y | $1.06 | +12,275.47% | +51.30% | +12,224.17 | 0 Comment | |
| stockcaps360 | < 20 | 8/1/2017 |
|
5Y | $1.06 | +12,275.47% | +51.30% | +12,224.17 | 0 Comment | |
| SoxFan33 | 98.47 | 8/23/2011 |
|
5Y | $1.21 | +10,750.29% | +225.52% | +10,524.77 | 0 Comment | |
| TMFGBudwell | 78.95 | 1/2/2018 |
|
1Y | $1.28 | +10,148.44% | +39.56% | +10,108.88 | 1 Comment | |
| jimscottage11 | 69.80 | 12/23/2011 |
|
5Y | $1.27 | +10,229.13% | +197.93% | +10,031.20 | 0 Comment | |
| samedii | 78.86 | 4/3/2012 |
|
5Y | $1.28 | +10,148.44% | +164.92% | +9,983.52 | 0 Comment | |
| rty168 | 52.11 | 8/11/2011 |
|
5Y | $1.28 | +10,179.76% | +229.27% | +9,950.49 | 0 Comment | |
| DigitalBandit | 77.85 | 3/23/2012 |
|
5Y | $1.32 | +9,837.88% | +168.57% | +9,669.31 | 0 Comment | |
| RBuskey106 | 59.33 | 3/22/2012 |
|
5Y | $1.33 | +9,763.16% | +169.01% | +9,594.15 | 1 Comment | |
| iadops40 | 61.84 | 3/12/2012 |
|
1Y | $1.36 | +9,545.59% | +172.20% | +9,373.39 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
